For research purposes only. Not for human consumption. Not medical advice.
PT-141 / Bremelanotide
Price updated daily
Sex & Libido
PT-141 (Bremelanotide) is an FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women. Unlike PDE5 inhibitors, it acts centrally in the brain to increase sexual desire rather than peripherally on blood flow. It is effective in both men and women for enhancing libido and sexual function.
Research Use Cases
- Libido and sexual desire enhancement
- Female sexual interest/arousal disorder (HSDD)
- Erectile function support (central mechanism)
- Sexual dysfunction management
Note: Can cause nausea and transient blood pressure elevation. FDA-approved for women (Vyleesi).